Allegra and Ibrance drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Allegra (fexofenadine hydrochloride) and Ibrance (palbociclib). Common drug interactions include white blood cell count decreased among females.
The phase IV clinical study analyzes what interactions people have when they take Allegra and Ibrance. It is created by eHealthMe based on reports of 166 people who take the same drugs from the FDA, and is updated regularly.
What is Allegra?
Allegra has active ingredients of fexofenadine hydrochloride. It is often used in allergies. eHealthMe is studying from 75,498 Allegra users. Check the latest studies of Allegra.
What is Ibrance?
Ibrance has active ingredients of palbociclib. eHealthMe is studying from 104,434 Ibrance users. Check the latest studies of Ibrance.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
166 people who take Allegra and Ibrance together, and have interactions are studied.
What are the common drug interactions of Allegra and Ibrance, by gender? *
What are the common drug interactions of Allegra and Ibrance, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Allegra and Ibrance?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Allegra and Ibrance:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Allegra:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Ibrance:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Allegra and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ibrance and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on fexofenadine hydrochloride and palbociclib (the active ingredients of Allegra and Ibrance, respectively), and Allegra and Ibrance (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Celexa and Prilosec Otc - 12 seconds ago
- Swelling and drugs of ingredients of doxycycline hyclate - 17 seconds ago
- Glucosamine vs. Celecoxib, side effect and effectiveness comparison - a minute ago
- Drug interactions of Otrexup and Cosentyx - a minute ago
- Could Pomalidomide cause Asthma? - a minute ago
- Could Ultracet cause Delirium? - 2 minutes ago
- Synthroid and Injection Site Extravasation for Women aged 50-59 - 3 minutes ago
- Could Olanzapine cause Bronchospasm Aggravated? - 3 minutes ago
- Drug interactions of Yasmin and Asa - 3 minutes ago
- Meclizine Hydrochloride vs. Dramamine, side effect and effectiveness comparison - 4 minutes ago